Cargando…
Monitoring α-synuclein aggregation
Synucleinopathies, including Parkinson's disease (PD), dementia with Lewy Bodies (DLB), and multiple system atrophy (MSA), are characterized by the misfolding and subsequent aggregation of alpha-synuclein (α-syn) that accumulates in cytoplasmic inclusions bodies in the cells of affected brain r...
Autores principales: | Estaun-Panzano, Juan, Arotcarena, Marie-Laure, Bezard, Erwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875312/ https://www.ncbi.nlm.nih.gov/pubmed/36527982 http://dx.doi.org/10.1016/j.nbd.2022.105966 |
Ejemplares similares
-
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
por: Teil, Margaux, et al.
Publicado: (2020) -
Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate
por: Canron, Marie-Hélène, et al.
Publicado: (2012) -
Acidic nanoparticles protect against α‐synuclein‐induced neurodegeneration through the restoration of lysosomal function
por: Arotcarena, Marie‐Laure, et al.
Publicado: (2022) -
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity
por: Ysselstein, Daniel, et al.
Publicado: (2017) -
Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson’s disease
por: Laferrière, Florent, et al.
Publicado: (2022)